For instance, gene fusion of FGFR2 RTK was reported to occur in around 20% ICC patients [41], and BRAF RTK mutations at the V600E locus have been identified in approximately 5% of ICC cases [42]. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.